Not FDA-approved No company has submitted Melanotan 2 for FDA approval
however, residual confounding by baseline BMI, glycemic status, indication, and discontinuation timing remains difficult to exclude (137)
Vials should not be frozen, as freezing can compromise stopper integrity
Over the last few years, patients and clinicians began observing unexpected fertility outcomes on GLP-1 therapy: Improved menstrual regularity Spontaneous ovulation Unplanned pregnancies - leading to the now-viral term Ozempic babies While much of the current data is anecdotal, emerging research is starting to explore this link in greater depth
The ATTAIN-MAINTAIN trial demonstrated that patients switching from tirzepatide to orforglipron maintained most of their weight loss, with modest regain of approximately 5 kg on average
Most patients see the difference within 3-6 months, with optimal results coming in around 6-8 months later